All Stories

  1. A Complex Methodological Approach for the Screening of Efficient and Safe Cobalt Chelators
  2. Blood and Plasma Volumetric Absorptive Microsampling (VAMS) Coupled to LC-MS/MS for the Forensic Assessment of Cocaine Consumption
  3. Analysis of Artemisia annua extracts and related products by high performance liquid chromatography-tandem mass spectrometry coupled to sample treatment miniaturisation
  4. An Original HPLC Method with Coulometric Detection to Monitor Hydroxyl Radical Generation via Fenton Chemistry
  5. Botanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins of Pharmaceutical Interest
  6. Duloxetine plasma level and antidepressant response
  7. Cannabinoids from Cannabis sativa L.: A New Tool Based on HPLC–DAD–MS/MS for a Rational Use in Medicinal Chemistry
  8. Perspectives and strategies for anti-doping analysis
  9. Berberine and Tinospora cordifolia exert a potential anticancer effect on colon cancer cells by acting on specific pathways
  10. Effects of oral d-aspartate on sperm quality in B6N mice
  11. Feedback from the fourth European Bioanalysis Forum Young Scientist Symposium
  12. Encapsulations of wild garlic (Allium ursinum L.) extract using spray congealing technology
  13. Tutorial: Volumetric absorptive microsampling (VAMS)
  14. Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches
  15. A simple, cheap but reliable method for evaluation of zinc chelating properties
  16. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs
  17. Enantioseparation and determination of asenapine in biological fluid micromatrices by HPLC with diode array detection
  18. Novel mixed vesicles containing lactobacilli biosurfactant for vaginal delivery of an anti- Candida agent
  19. Metabolism of Drugs Used in the Therapy of Seizures: An Analytical Point of View. Part 1
  20. Analytical profiling of selected antioxidants and total antioxidant capacity of goji ( Lycium spp.) berries
  21. Increased oxytocin levels among abstinent heroin addicts: Association with aggressiveness, psychiatric symptoms and perceived childhood neglect
  22. Dried haematic microsamples and LC–MS/MS for the analysis of natural and synthetic cannabinoids
  23. Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis
  24. Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease
  25. Phytochemical analysis and antibacterial activity towards methicillin-resistant Staphylococcus aureus of leaf extracts from Argania spinosa (L.) Skeels
  26. LC–MS/MS and volumetric absorptive microsampling for quantitative bioanalysis of cathinone analogues in dried urine, plasma and oral fluid samples
  27. Analysis of γ-hydroxy butyrate by combining capillary electrophoresis-indirect detection and wall dynamic coating: application to dried matrices
  28. Analytical Profiling of Bioactive Phenolic Compounds in Argan (Argania spinosa ) Leaves by Combined Microextraction by Packed Sorbent (MEPS) and LC-DAD-MS/MS
  29. Current advances in biosampling for therapeutic drug monitoring of psychiatric CNS drugs
  30. TDM of novel antipsychotics
  31. Bioactive molecules as authenticity markers of Italian Chinotto (Citrus×myrtifolia) fruits and beverages
  32. Microextraction by packed sorbent (MEPS) to analyze catecholamines in innovative biological samples
  33. Discontinued anxiolytic drugs (2009 – 2014)
  34. Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder
  35. Multi-matrix assay of the first melatonergic antidepressant agomelatine by combined liquid chromatography-fluorimetric detection and microextraction by packed sorbent
  36. Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients
  37.  9-Tetrahydrocannabinol-induced anti-inflammatory responses in adolescent mice switch to proinflammatory in adulthood
  38. A fast and feasible microextraction by packed sorbent (MEPS) procedure for HPLC analysis of the atypical antipsychotic ziprasidone in human plasma
  39. Evaluation of the pharmacokinetics, safety and clinical efficacy of sertraline used to treat social anxiety
  40. Recent trends in the analysis of amino acids in fruits and derived foodstuffs
  41. Monitoring of chronic Cannabis abuse: An LC–MS/MS method for hair analysis
  42. Quantitative Evaluation of Auraptene and Umbelliferone, Chemopreventive Coumarins in Citrus Fruits, by HPLC-UV-FL-MS
  43. Dried blood spots: Liquid chromatography–mass spectrometry analysis of Δ9-tetrahydrocannabinol and its main metabolites
  44. Validation of a dried blood spot LC–MS/MS approach for cyclosporin A in cat blood: Comparison with a classical sample preparation
  45. Selective Serotonin Reuptake Inhibitors (SSRIs): Therapeutic Drug Monitoring and Pharmacological Interactions
  46. Ketoconazole-Associated Preferential Increase in Dopamine D2 Receptor Occupancy in Striatum Compared to Pituitary In Vivo
  47. Content of melatonin and other antioxidants in grape-related foodstuffs: measurement using a MEPS-HPLC-F method
  48. Fast analysis of amino acids in wine by capillary electrophoresis with laser-induced fluorescence detection
  49. Chiral analysis of amphetamines, methadone and metabolites in biological samples by electrodriven methods
  50. Determination of aloe emodin in Aloe vera extracts and commercial formulations by HPLC with tandem UV absorption and fluorescence detection
  51. Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV
  52. Metabolism of Benzodiazepine and Non-Benzodiazepine Anxiolytic-Hypnotic Drugs: an Analytical Point of View
  53. Analysis of cocaine and two metabolites in dried blood spots by liquid chromatography with fluorescence detection: A novel test for cocaine and alcohol intake
  54. Simultaneous HPLC-F analysis of three recent antiepileptic drugs in human plasma
  55. Analysis of Aloe-based phytotherapeutic products by using nano-LC-MS
  56. Fast CE analysis of adrenergic amines in different parts of Citrus aurantium fruit and dietary supplements
  57. Enhanced expression of the neuronal K+/Cl− cotransporter, KCC2, in spontaneously depressed Flinders Sensitive Line rats
  58. Simultaneous HPLC determination of 14 tricyclic antidepressants and metabolites in human plasma
  59. Simultaneous analysis of diazepam and its metabolites in rat plasma and brain tissue by HPLC-UV and SPE
  60. Fast analysis of catecholamine metabolites MHPG and VMA in human plasma by HPLC with fluorescence detection and a novel SPE procedure
  61. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery
  62. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery
  63. Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines
  64. Determination of insulin in innovative formulations by means of LC coupled to fluorescence detection
  65. Benzodiazepine Metabolism: An Analytical Perspective
  66. Quantitative analysis of cocaine in human hair by HPLC with fluorescence detection
  67. Separation and HPLC analysis of 15 benzodiazepines in human plasma
  68. HPLC analysis of the antidepressant trazodone and its main metabolite m-CPP in human plasma
  69. Comparison of analytical methods for the quality control of a new formulation containing soy extract and melatonin
  70. Determination of plasma and urine levels of Δ9-tetrahydrocannabinol and its main metabolite by liquid chromatography after solid-phase extraction
  71. HPLC-F analysis of melatonin and resveratrol isomers in wine using an SPE procedure
  72. Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection
  73. HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure
  74. Determination of sertraline andN-desmethylsertraline in human plasma by CE with LIF detection
  75. Determination of the antidepressant paroxetine and its three main metabolites in human plasma by liquid chromatography with fluorescence detection
  76. Simultaneous analysis of classical neuroleptics, atypical antipsychotics and their metabolites in human plasma
  77. Simultaneous determination of methadone, buprenorphine and norbuprenorphine in biological fluids for therapeutic drug monitoring purposes
  78. Simultaneous determination of the antipsychotic drugs levomepromazine and clozapine and their main metabolites in human plasma by a HPLC-UV method with solid-phase extraction
  79. Simultaneous determination of fluvoxamine isomers and quetiapine in human plasma by means of high-performance liquid chromatography
  80. Determination of homovanillic acid (HVA) in human plasma by HPLC with coulometric detection and a new SPE procedure
  81. Determination of the antidepressant mirtazapine and its two main metabolites in human plasma by liquid chromatography with fluorescence detection
  82. Erratum
  83. A rapid HPLC-DAD method for the analysis of fluoxetine and norfluoxetine in plasma from overdose patients